- 영문명
- A Study On Compositions, Dosages and Usages of Sagunjatang, Samultang, Palmultang, Sipjeondaebotang in Literature
- 발행기관
- 대한한의학원전학회
- 저자명
- 이경구(Kyung-Goo Lee) 황대선(Dae-Sun Huang) 유영법(Young-Beob Yu) 마진열(Jin-Yeul Ma) 하혜경(Hye-Kyeong Ha) 신현규(Hyeun-Kyoo Shin)
- 간행물 정보
- 『대한한의학원전학회지』19권 4호, 219~225쪽, 전체 6쪽
- 주제분류
- 의약학 > 한의학
- 파일형태
- 발행일자
- 2006.11.30

국문 초록
영문 초록
The result is the followings after investigating composition, dosage and usage of Sagunjatang(四君子湯), Samultang(四物湯), Palmultang(八物湯), Sipjeondaebotang(十全大補湯) in literature by country and Era
1. Sagunjatang has become equal to Panax ginseng(人蔘), Atractylodes japonica(白朮), Poria cocos(복령) each for 2 Jeon(錢), Glycyrrhiza uralensis(甘草) 1 Jeon since the Ming Dynasty in China and it is standardized by Panax ginseng, Atractylodes japonica, Poria cocos and Glycyrrhiza uralensis each for 1 Jeon 2 Pun(分) 5 Ri(里) since Dongeuibogam in Korea
2. Samultang has become equal to Angelica gigas(當歸) and Rehmannia glutinosa(地黃) each three Jeon, Cnidium officinale(川芎) is 1 Jeon 2 Pun or 1 Jeon and Paeonia lactiflora(芍藥) 2 Jeon since the Ming Dynasty in China and it is standardized by Angelica gigas, Cnidium officinale, Paeonia lactiflora and Rehmannia glutinosa each for 1 Jeon 2 Pun 5 Ri since Dongeuibogam in Korea
3. In the case of Palmultang, compositional usage of medicine was different in the Ming Dynastry and the Ching(靑) Dynastry in China. Total dosage was increased and ratio of Angelica gigas and Rehmannia glutinosa was increased comparatively in the Ching Dynasty. All prescription of medicine was consisted of 1 Jeon 2 Pun and specific dosage was presented except Euirimchwalyo(醫林撮要) that dosage was not recorded in Korea
4. Sipjeondaebotang tended to increase total dosage in the latter part in China. Dosage was mostly used 1 Jeon thus Dongeuibogam but Bangyakhap(方藥合編) used 1 Jeon 5 Pun differentially
목차
Abstract
Ⅰ. 서론
Ⅱ. 조사 방법
Ⅲ. 본론
Ⅳ. 결론
Ⅴ. 참고문헌
해당간행물 수록 논문
참고문헌
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
